Cabaletta Bio
Overview
Cabaletta Bio is a clinical-stage biotechnology company working to develop and launch engineered T cell therapies for patients with autoimmune diseases.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Cabaletta Bio in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.